$99.74
1.20% yesterday
NYSE, Jun 13, 10:10 pm CET
ISIN
US1011371077
Symbol
BSX

Boston Scientific Stock price

$99.74
-3.21 3.12% 1M
+9.63 10.69% 6M
+10.42 11.67% YTD
+22.78 29.60% 1Y
+63.87 178.06% 5Y
+82.37 474.21% 10Y
+71.04 247.53% 20Y
NYSE, Closing price Fri, Jun 13 2025
+1.18 1.20%
ISIN
US1011371077
Symbol
BSX
Sector

Key metrics

Market capitalization $147.56b
Enterprise Value $158.14b
P/E (TTM) P/E ratio 72.80
EV/FCF (TTM) EV/FCF 52.47
EV/Sales (TTM) EV/Sales 9.01
P/S ratio (TTM) P/S ratio 8.41
P/B ratio (TTM) P/B ratio 6.64
Revenue growth (TTM) Revenue growth 19.35%
Revenue (TTM) Revenue $17.55b
EBIT (operating result TTM) EBIT $3.30b
Free Cash Flow (TTM) Free Cash Flow $3.01b
Cash position $725.00m
EPS (TTM) EPS $1.37
P/E forward 51.99
P/S forward 7.57
EV/Sales forward 8.11
Short interest 1.15%
Show more

Is Boston Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Boston Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Boston Scientific forecast:

30x Buy
88%
4x Hold
12%

Analyst Opinions

34 Analysts have issued a Boston Scientific forecast:

Buy
88%
Hold
12%

Financial data from Boston Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
17,553 17,553
19% 19%
100%
- Direct Costs 5,502 5,502
22% 22%
31%
12,051 12,051
18% 18%
69%
- Selling and Administrative Expenses 6,217 6,217
16% 16%
35%
- Research and Development Expense 1,693 1,693
17% 17%
10%
4,158 4,158
23% 23%
24%
- Depreciation and Amortization 862 862
3% 3%
5%
EBIT (Operating Income) EBIT 3,296 3,296
30% 30%
19%
Net Profit 2,033 2,033
15% 15%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Boston Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Boston Scientific Stock News

Positive
Market Watch
4 days ago
Analysts have been cutting their estimates for companies' sales and profits, but there are always exceptions to trends.
Positive
Seeking Alpha
15 days ago
Boston Scientific is a global leader in medical devices, excelling in both MedSurg and Cardiovascular segments with consistent, industry-beating growth. Q1 2024 was a record quarter, with 21% YoY revenue growth, strong margins, and EPS beating expectations by $0.08. Organic growth and strategic acquisitions fuel BSX's expansion, supported by a diverse portfolio and active venture investments.
Neutral
Seeking Alpha
17 days ago
Boston Scientific Corporation (NYSE:BSX ) Bernstein 41st Annual Strategic Decisions Conference Call May 28, 2025 8:01 AM ET Company Participants Michael Mahoney - Chairman and Chief Executive Officer Kenneth Stein - Senior Vice President and Global Chief Medical Officer Conference Call Participants Lee Hambright - Sanford C. Bernstein & Co., LLC Lee Hambright Okay.
More Boston Scientific News

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Head office United States
CEO Michael Mahoney
Employees 53,000
Founded 1979
Website www.bostonscientific.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today